OBJECTIVE: 1) Identify key clinical, biochemical, cytological and sonographic predictors of malignancy in cytologically indeterminate thyroid nodule. 2) Quantify the risk of malignancy using a formula derived from regression analysis.
patients, initially treated at our institution, are counted twice). Neck dissections consisted of levels II-V in 36 (46%), , and I-V in 14 (18%) necks. The remaining 13 (17%) necks were dissected at a single level (nϭ8) or multiple levels (nϭ5) not noted above. Among all necks treated, metastatic adenopathy was confirmed pathologically as follows: 2.6% level I, 38% level II, 45% level III, 47% level IV, and 17% level V. Comparing primary and recurrent disease, there was no difference in nodal distribution for levels I-III. Level IV was positive in 33% of primary and 60% of recurrent groups (pϭ0.04). Level V was positive in 14% of primary and 19% of recurrent groups (pϭ0.70). Adjuvant I-131 was given in 30 (97%) primary cases and 14 (38 %) recurrent cases. At median follow-up of 37 (1-120) months, neck control was seen in 76 (97%) with only one recurrence (99% control) within a previously operated neck level. CONCLUSION: Neck dissection in PTC gives excellent control of regional disease. Based on the pathologic distribution of nodes, dissection should routinely include levels II-IV with attention and inclusion of level V based on imaging and intra-operative findings. Routine level I dissection is not necessary.
Management Challenges in Supernumerary Parathyroid Adenoma
Jason Showmaker, BS (presenter); Matthew Page, MD; Jeffrey Jorgensen, MD; Robert P. Zitsch III, MD OBJECTIVE: 1) To present the management difficulties when primary hyperparathyroidism is complicated by mediastinal adenoma in a supernumerary parathyroid gland (SPG), and 2) To offer the authors' considerations for the management of this situation based on this experience and a literature review. METHOD: An individual patient's clinical records were examined, and the pertinent literature was reviewed. RESULTS: We describe a case of primary hyperparathyroidism in a 60 year old male with critically elevated iCa of 2.09mmol/L and iPTH of 1164pg/mL. Preoperative localization studies were negative. A left superior adenoma was identified intraoperatively; however, the ten-minute post-excision rapid intraoperative PTH level paradoxically increased from preoperative baseline. Examination of the remaining glands revealed diffuse hyperplasia, and the patient underwent fourgland removal with 1/2 gland autotransplantation. There was minimal reduction of iPTH to 761pg/mL. The presence of a hyperfunctioning SPG was suspected and a comprehensive exploration of acknowledged ectopic locations failed to identify a fifth gland. Postoperatively, hyperparathyroidism persisted, and an MRI revealed an 18mm mass in the superior mediastinum which was excised via sternotomy and proved to be a second adenoma. The iPTH declined to normal range, and normocalcemia has persisted after a follow-up period of six months.
CONCLUSION:
This case of persistent hyperparathyroidism after three 1/2-gland parathyroidectomy was caused by a second adenoma in a mediastinal SPG that eluded preoperative imaging and a careful neck exploration. It serves to enlighten parathyroid surgeons of the impact of SPGs and to offer considerations for their challenging management.
Management of Advanced Thyroid Malignancy
Kamrul Hasan Tarafder, MBBS, FCPS, FICS (presenter); Pran Gopal Datta; Hasanur Rahman Nasima Akhtar OBJECTIVE: To see the effectiveness of the management of advanced thyroid cancer according to the protocol used in the otolaryngology department of BSM Medical University. METHOD: Non-randomized prospective study on advanced cases of thyroid malignancy were marked on the basis of extracapsular spread/Local invasion, regional &/or distal metastasis during a period of seven years (1998) (1999) (2000) (2001) (2002) (2003) (2004) (2005) . RESULTS: Two-hundred and fifty-nine consecutive cases of thyroid malignancy were treated within the study period. Papillary & Follicular carcinoma formed the main bulk (89%). About 54% cases presented at an advanced stage. Among the advanced cases 82% presented with lymphatic metastasis, skeletal (sternum, skull, ribs, jaw or femur), pulmonary & brain metastasis were found in 5%, 12% and 1.5% respectively. Local invasion to trachea, larynx, pharynx or esophagus was found in 12.23% cases, fixity to great vessels in neck and recurrent laryngeal nerve involvement was found in 6.47% & 15.51% cases. In 6.47% cases no definitive treatment could be offered. Surgery (92%) and radioiodine ablation (86%) were mainstay of treatment; external beam radiation was used in 4% cases. Perioperative mortality was seen in 5 cases. Cases were followed up for a mean period of 5.2 years; 30.40% cases were lost to follow up. Among the respondents mortality was 19.54% and recurrence was seen in 25% cases. CONCLUSION: With definitive treatment of advanced thyroid carcinoma there is a high chance of recurrence which is again treatable in most of the cases. The mortality is also much higher than that of early thyroid malignancy.
